@prefix this: . @prefix sub: . @prefix schema: . @prefix np: . @prefix dct: . @prefix rdf: . @prefix nt: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix bl: . @prefix nkg: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { bl:category bl:Disease . sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "Pitolisant and sodium oxybate show promising results in two retrospective studies. The efficacy of γ-aminobutyric acid-A receptor antagonists on objective EDS needs to be clarified. All these medications are used off-label for the management of EDS in IH."; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:has_population_context sub:cohort; bl:provided_by ; bl:publications ; bl:relation nkg:OffLabelIndication . sub:cohort rdfs:label "Adults"; schema:requiredMinAge "Adults"; bl:category bl:Cohort; bl:has_phenotype . bl:category bl:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"; npx:hasSignature "PCn19b7Q4U1Dyn81tCVO0a/VlKqQ2oNUzmgtU/RD9aPVb7rAeS8kDzuH5eZnnGSsE1dsGpOMUPmZpkCJSaff6uuwcPWe5YdW7LVj8YGl0I1K0ASaUXxWUthNBgth6dSun4ZA1C65QEDXeRfCMXL+ANnDUPs/uQurgiYyyeTmfe8="; npx:hasSignatureTarget this: . this: dct:created "2021-06-07T15:04:08.125+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-7641-6446; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }